Concepedia

Increased osteocyte death in multiple myeloma patients: role in myeloma-induced osteoclast formation

Nicola Giuliani, Marzia Ferretti, Marina Bolzoni, Paola Storti, Mirca Lazzaretti, Benedetta Dalla Palma, Sabrina Bonomini, E Martella, Luca Agnelli, Antonino Neri,

Leukemia · 2012 · 141 citations · 45 references

DOIFull text

Open access

Concepts

References

45

Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone.

Robert S. Weinstein, R L Jilka, A. M. Parfitt et al. · Journal of Clinical Investigation · 1998 · 1.8K citations · Full text

, , +16

The Role of the Wnt-Signaling Antagonist DKK1 in the Development of Osteolytic Lesions in Multiple Myeloma

Erming Tian, Fenghuang Zhan, Ronald C. Walker et al. · New England Journal of Medicine · 2003 · 1.5K citations · Full text

, , +17

Osteocyte control of bone formation via sclerostin, a novel BMP antagonist

D. G. Winkler · The EMBO Journal · 2003 · 1.1K citations · Full text

, , +13

Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin

Lilian I. Plotkin, Robert S. Weinstein, A. M. Parfitt et al. · Journal of Clinical Investigation · 1999 · 893 citations · Full text

, , +17

Sclerostin Is an Osteocyte-expressed Negative Regulator of Bone Formation, But Not a Classical BMP Antagonist

Rutger L. van Bezooijen, Bernard A.J. Roelen, Annemieke Visser et al. · The Journal of Experimental Medicine · 2004 · 883 citations · Full text

, , +15